Ryzodeg 70/30 Interactions
There are 392 drugs known to interact with Ryzodeg 70/30 (insulin aspart/insulin degludec), along with 3 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 15 are major, 356 are moderate, and 21 are minor.
- View all 392 medications that may interact with Ryzodeg 70/30
- View Ryzodeg 70/30 alcohol/food interactions (2)
- View Ryzodeg 70/30 disease interactions (3)
Most frequently checked interactions
View interaction reports for Ryzodeg 70/30 (insulin aspart/insulin degludec) and the medicines listed below.
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- Byetta (exenatide)
- candesartan
- clopidogrel
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- dapagliflozin
- Eliquis (apixaban)
- escitalopram
- Exforge (amlodipine / valsartan)
- ezetimibe
- fenofibrate
- Fish Oil (omega-3 polyunsaturated fatty acids)
- insulin aspart
- insulin glargine
- Jardiance (empagliflozin)
- Lipitor (atorvastatin)
- metformin
- mirtazapine
- Ozempic (semaglutide)
- pantoprazole
- Paracetamol (acetaminophen)
- perindopril
- prazosin
- rosuvastatin
- Tradjenta (linagliptin)
- Vitamin D3 (cholecalciferol)
Ryzodeg 70/30 alcohol/food interactions
There are 2 alcohol/food interactions with Ryzodeg 70/30 (insulin aspart/insulin degludec).
Ryzodeg 70/30 disease interactions
There are 3 disease interactions with Ryzodeg 70/30 (insulin aspart/insulin degludec) which include:
More about Ryzodeg 70/30 (insulin aspart/insulin degludec)
- Ryzodeg 70/30 consumer information
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: insulin
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.